Erdogan to tell Trump: US has not met Syria cease-fire obligations

‘I will tell him, with the use of documents, that the agreement we reached on the operation has not been fully implemented,’ Turkish President Recep Tayyip Erdogan said on Tuesday. (AP)
Updated 12 November 2019

Erdogan to tell Trump: US has not met Syria cease-fire obligations

  • ‘I will tell him, with the use of documents, that the agreement we reached on the operation has not been fully implemented’

ANKARA: Turkish President Recep Tayyip Erdogan said Tuesday he would tell US counterpart Donald Trump that Washington must do more to implement a cease-fire deal they agreed in order to halt Turkey’s offensive in Syria.

As he prepared to leave for Washington, Erdogan told reporters: “I will tell him, with the use of documents, that the agreement we reached on the operation has not been fully implemented.”

Turkey struck a deal with the United States on October 17 to suspend its military offensive in northern Syria, in return for Washington ensuring a pullout of Syrian Kurdish forces from a proposed “safe zone.”

Ankara concluded a separate deal with Russia a few days later under which Moscow agreed to ensure the withdrawal of Kurdish forces from adjacent areas.

Turkey launched the offensive last month to push Kurdish militants back from its border and create room to repatriate Syrian refugees.

But Erdogan said Kurdish “terror groups” had still not left key towns, including Manbij, Tal Abyad, Qamishli and Tal Rifaat.

“Unfortunately, as of now it is not possible to say terror groups have withdrawn from the region,” he said.

“Neither Russia nor the United States could remove terror groups within the given hour and the given day.”

The Turkish leader said he would raise the issue with Trump, and after his return, with Russian President Vladimir Putin by phone.

Erdogan’s visit to Washington comes at a tense time in bilateral ties because of disputes over the Syrian conflict and the US House of Representatives recognizing the mass killing of Armenians a century ago as genocide.

But Erdogan said: “Despite the fog in our relations, we are in agreement ... with Mr. Trump to improve our relations.”


Mideast faces opioid crisis as it rages through developing world

Updated 13 December 2019

Mideast faces opioid crisis as it rages through developing world

  • Mass abuse of the opioid tramadol spans continents, from India to Africa to the Middle East
  • Abuse is now so rampant some countries consumed by it are asking international authorities to intervene

KAPURTHALA: Reports rolled in with escalating urgency — pills seized by the truckload, pills swallowed by schoolchildren, pills in the pockets of dead terrorists.
These pills, the world has been told, are safer than the OxyContins, the Vicodins, the fentanyls that have wreaked so much devastation. But now they are the root of what the United Nations named “the other opioid crisis” — an epidemic featured in fewer headlines than the American one, as it rages through the most vulnerable countries on the planet.
Mass abuse of the opioid tramadol spans continents, from India to Africa to the Middle East, creating international havoc some experts blame on a loophole in narcotics regulation and a miscalculation of the drug’s danger. The man-made opioid was touted as able to relieve pain with little risk of abuse. Unlike other opioids, tramadol flowed freely around the world, unburdened by international controls that track most dangerous drugs.
But abuse is now so rampant some countries consumed by it are asking international authorities to intervene.

Grunenthal, the German company that originally made the drug, is campaigning for the status quo, arguing international regulations make narcotics difficult to get in countries with disorganized health systems, and adding tramadol to the list would deprive patients in pain access to any opioid at all.
“This is a huge public health dilemma,” said Dr. Gilles Forte, the secretary of the World Health Organization’s committee that recommends how drugs should be regulated. Tramadol is available in war zones and impoverished nations because it is unregulated. But it is widely abused for the same exact reason. “It’s a really very complicated balance to strike.”
Tramadol is not as deadly as other opioids and the crisis isn’t killing with the ferocity of America’s struggle withe the drugs. Still, individual governments from the US to Egypt to Ukraine have realized the drug’s dangers are not as limited as believed and worked to rein in the tramadol trade. The north Indian state of Punjab, the center of India’s opioid epidemic, was the latest to crack down. The pills were everywhere, as legitimate medication sold in pharmacies, but also illicit counterfeits hawked by street vendors.
This year, authorities seized hundreds of thousands of tablets, banned most pharmacy sales and shut down counterfeit pill factories, pushing the price from 35 cents for a 10-pack to $14. The government opened a network of treatment centers, fearing those who had become opioid addicted would resort to heroin out of desperation. Hordes of people rushed in to seek help in dealing with excruciating withdrawal.
For some, tramadol had become as essential as food.
“Like if you don’t eat, you start to feel hungry. Similar is the case with not taking it,” said auto shop welder Deepak Arora, a gaunt 30-year-old who took 15 tablets day, so much he had to steal from his family to pay for pills. “You are like a dead person.”
Jeffery Bawa, an officer with the United Nations Office on Drugs and Crime, realized what was happening in 2016.
Police began finding pills on terrorists, who traffic it to fund their networks and take it to bolster their capacity for violence, Bawa said.
Most of it was coming from India. The country’s sprawling pharmaceutical industry is fueled by cheap generics. Pill factories produce knock-offs and ship them in bulk around the world, in doses far exceeding medical limits.
In 2017, law enforcement reported that $75 million worth of tramadol from India was confiscated en route to the Islamic State terror group. Authorities intercepted 600,000 tablets headed for Boko Haram. Another 3 million were found in a pickup truck in Niger, in boxes disguised with UN logos. The agency warned that tramadol was playing “a direct role in the destabilization of the region.”
“We cannot let the situation get any further out of control,” that alert read.
Grunenthal has campaigned to keep tramadol unregulated. It funded surveys that found regulation would impede pain treatment, and paid consultants to travel to the WHO to make the case that it’s safer that other opioids.
Spokesman Stepan Kracala said regulation would not necessarily curtail illicit trade and could backfire: Some desperate pain patients turn to the black market if no legal options exist.
This has happened in India, which regulated tramadol in 2018. Regulators say exports overseas and abuse at home came down. But they acknowledge that the vastness of the pharmaceutical industry and the ingenuity of traffickers makes curtailing abuse and illegal exports all but impossible. Tramadol is still easy to find.
Jyoti Rani stood on her front steps and pointed to house after house in the small city of Kapurthala where she said tramadol is still sold in her neighborhood of narrow roads and open drains, where school-aged boys sit hunched over the street in the middle of a weekday.
Rani’s addiction began with heroin. When her 14-year-old son died, she fell into depression.
“I wanted to kill myself, but I ended up becoming an addict,” she cried. A doctor prescribed tramadol to help kick the habit — instead, she formed a new one.
Now she is among about 30,000 people in Punjab who go to government-run addiction clinics for daily treatment.
Countries’ efforts to control tramadol on their own often fail, according to the Center for Strategic and International Studies, particularly in places where addiction has taken hold.